DBV Technologies SA (DBVT)
0.6669
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.662
0.00 (0.00%)
Pre-Market: 20:00
DBV Technologies 1 Year Total Returns (Daily): -57.25% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -57.25% |
May 02, 2024 | -55.63% |
May 01, 2024 | -54.00% |
April 30, 2024 | -55.60% |
April 29, 2024 | -53.61% |
April 26, 2024 | -57.11% |
April 25, 2024 | -54.94% |
April 24, 2024 | -56.54% |
April 23, 2024 | -56.69% |
April 22, 2024 | -57.90% |
April 19, 2024 | -58.43% |
April 18, 2024 | -59.20% |
April 17, 2024 | -57.23% |
April 16, 2024 | -60.19% |
April 15, 2024 | -60.51% |
April 12, 2024 | -58.66% |
April 11, 2024 | -58.33% |
April 10, 2024 | -56.91% |
April 09, 2024 | -57.33% |
April 08, 2024 | -55.23% |
April 05, 2024 | -55.49% |
April 04, 2024 | -59.65% |
April 03, 2024 | -56.14% |
April 02, 2024 | -54.74% |
April 01, 2024 | -53.85% |
Date | Value |
---|---|
March 28, 2024 | -53.76% |
March 27, 2024 | -52.96% |
March 26, 2024 | -50.87% |
March 25, 2024 | -50.32% |
March 22, 2024 | -51.45% |
March 21, 2024 | -49.69% |
March 20, 2024 | -47.40% |
March 19, 2024 | -46.93% |
March 18, 2024 | -48.67% |
March 15, 2024 | -49.68% |
March 14, 2024 | -49.82% |
March 13, 2024 | -49.02% |
March 12, 2024 | -46.83% |
March 11, 2024 | -47.53% |
March 08, 2024 | -50.40% |
March 07, 2024 | -45.30% |
March 06, 2024 | -45.37% |
March 05, 2024 | -41.33% |
March 04, 2024 | -40.83% |
March 01, 2024 | -42.76% |
February 29, 2024 | -43.45% |
February 28, 2024 | -44.57% |
February 27, 2024 | -40.93% |
February 26, 2024 | -38.31% |
February 23, 2024 | -39.20% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.30%
Minimum
Sep 25 2020
267.1%
Maximum
Oct 21 2021
-24.64%
Average
-43.95%
Median
Aug 05 2022
1 Year Total Returns (Daily) Benchmarks
Biophytis SA | -94.31% |
Edap TMS SA | -37.64% |
Cellectis SA | 60.75% |
Genfit SA | -14.33% |
Adaptimmune Therapeutics PLC | -15.00% |